BridgeBio Pharma to Participate in September Investor Events
BridgeBio Pharma (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases, has announced its participation in three major investor conferences in September 2024:
1. Morgan Stanley 22nd Annual Global Health Care Conference in New York, NY on September 4th at 10:00 am ET (Fireside Conversation)
2. Wells Fargo 19th Annual Healthcare Conference 2024 in Boston, MA on September 5th
3. Cantor Global Healthcare Conference in New York, NY on September 17th at 10:20 am ET (Presentation)
Investors can access live webcasts of BridgeBio's presentations on the company's website. Replay of the webcasts will be available for 90 days following each event.
BridgeBio Pharma (Nasdaq: BBIO), un'azienda biofarmaceutica in fase commerciale specializzata nelle malattie genetiche, ha annunciato la sua partecipazione a tre importanti conferenze per investitori a settembre 2024:
1. 22ª Conferenza annuale globale sulla salute di Morgan Stanley a New York, NY, il 4 settembre alle 10:00 ET (Conversazione informale)
2. 19ª Conferenza annuale sulla salute di Wells Fargo 2024 a Boston, MA, il 5 settembre
3. Conferenza globale sulla salute di Cantor a New York, NY, il 17 settembre alle 10:20 ET (Presentazione)
Gli investitori possono accedere alle webcasting dal vivo delle presentazioni di BridgeBio sul sito web dell'azienda. La riproduzione delle webcasting sarà disponibile per 90 giorni dopo ciascun evento.
BridgeBio Pharma (Nasdaq: BBIO), una compañía biofarmacéutica en etapa comercial centrada en enfermedades genéticas, ha anunciado su participación en tres importantes conferencias para inversores en septiembre de 2024:
1. 22ª Conferencia Anual Global de Salud de Morgan Stanley en Nueva York, NY, el 4 de septiembre a las 10:00 am ET (Conversación junto a la chimenea)
2. 19ª Conferencia Anual de Salud de Wells Fargo 2024 en Boston, MA, el 5 de septiembre
3. Conferencia Global de Salud de Cantor en Nueva York, NY, el 17 de septiembre a las 10:20 am ET (Presentación)
Los inversores pueden acceder a las retransmisiones en vivo de las presentaciones de BridgeBio en el sitio web de la empresa. La repetición de las retransmisiones estará disponible durante 90 días después de cada evento.
브리지바이오 제약 (Nasdaq: BBIO)는 유전병에 초점을 맞춘 상업 단계 바이오제약 회사로, 2024년 9월에 열리는 3개의 주요 투자자 회의에 참여할 것이라고 발표했습니다:
1. 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스가 뉴욕, NY에서 9월 4일 오전 10시(동부 표준시) 열릴 예정입니다 (화로 옆 대화)
2. 웰스파고 제19회 연례 헬스케어 컨퍼런스 2024가 보스턴, MA에서 9월 5일 열립니다
3. 칸토 글로벌 헬스케어 컨퍼런스가 뉴욕, NY에서 9월 17일 오전 10시 20분(동부 표준시) 열릴 예정입니다 (발표)
투자자들은 브리지바이오의 발표를 회사 웹사이트에서 실시간으로 시청할 수 있습니다. 각 이벤트 후에는 90일 동안 재생 가능하게 됩니다.
BridgeBio Pharma (Nasdaq: BBIO), une entreprise biopharmaceutique en phase commerciale axée sur les maladies génétiques, a annoncé sa participation à trois grandes conférences d'investisseurs en septembre 2024 :
1. 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley à New York, NY, le 4 septembre à 10h00 ET (Discussion au coin du feu)
2. 19ème Conférence Annuelle sur la Santé de Wells Fargo 2024 à Boston, MA, le 5 septembre
3. Conférence Mondiale sur la Santé de Cantor à New York, NY, le 17 septembre à 10h20 ET (Présentation)
Les investisseurs peuvent accéder aux diffusions en direct des présentations de BridgeBio sur le site Web de l'entreprise. La rediffusion des diffusions sera disponible pendant 90 jours après chaque événement.
BridgeBio Pharma (Nasdaq: BBIO), ein biopharmazeutisches Unternehmen in der kommerziellen Phase, das sich auf genetische Krankheiten spezialisiert hat, hat seine Teilnahme an drei wichtigen Investorenkonferenzen im September 2024 angekündigt:
1. 22. Jahreskonferenz für globale Gesundheit von Morgan Stanley in New York, NY am 4. September um 10:00 Uhr ET (Gespräch am Kamin)
2. 19. jährliche Gesundheitskonferenz von Wells Fargo 2024 in Boston, MA am 5. September
3. Globale Gesundheitskonferenz von Cantor in New York, NY am 17. September um 10:20 Uhr ET (Präsentation)
Investoren können die Live-Übertragungen von BridgeBios Präsentationen auf der Website des Unternehmens abrufen. Die Wiederholung der Übertragungen wird 90 Tage nach jeder Veranstaltung verfügbar sein.
- None.
- None.
PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of the management team will participate in the following upcoming investor conferences:
- Morgan Stanley 22nd Annual Global Health Care Conference, New York, NY: Fireside Conversation on September 4th at 10:00 am ET
- Wells Fargo 19th Annual Healthcare Conference 2024, Boston, MA, September 5th
- Cantor Global Healthcare Conference, New York, NY: Presentation on September 17th at 10:20 am ET
To access the live webcast of BridgeBio’s presentations, please visit the “Events” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
BridgeBio Pharma (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015, and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, Twitter and Facebook.
BridgeBio Contact:
Vikram Bali
contact@bridgebio.com
(650)-789-8220
FAQ
What investor events will BridgeBio Pharma (BBIO) participate in during September 2024?
When and where is BridgeBio Pharma's (BBIO) presentation at the Cantor Global Healthcare Conference?
How can investors access BridgeBio Pharma's (BBIO) presentations at the September 2024 conferences?
How long will replays of BridgeBio Pharma's (BBIO) September 2024 conference presentations be available?
